Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Mercaptopurine Anhydrous
Burkitt Lymphoma
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Mercaptopurine Anhydrous
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Mesna
Hematopoietic And Lymphoid Cell Neoplasm
St. Jude Children's Research Hospital
P1/2
CCC
(48)
Mesna
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer Center
P1/2
CCC
(48)
Metformin
Arthropathy
ARKAY Therapeutics
P1/2
CCC
(48)
Metformin
Essential Hypertension
ARKAY Therapeutics
P1/2
CCC
(48)
Methadone
Colorectal Carcinoma
AIO-Studien-gGmbH
P1/2
CCC
(48)
Methotrexate
High Grade B-Cell Lymphoma
Northwestern University
P1/2
CCC
(48)
Methotrexate
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
Children's Oncology Group
P1/2
CCC
(48)
Methoxiflurane
Chronic Rhinosinusitis
St. Paul's Hospital, Canada
P1/2
CCC
(48)
Methoxyamine
Malignant Peritoneal Mesothelioma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Methoxyamine
Malignant Pleural Mesothelioma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Mib-626
Dementia
Brigham and Women's Hospital
P1/2
CCC
(48)
Midazolam
Mixed Phenotype Acute Leukemia
Kura Oncology, Inc.
P1/2
CCC
(48)
Midazolam
Acute Myeloid Leukemia With 11q23 Abnormalities
Kura Oncology, Inc.
P1/2
CCC
(48)
Minoxidil
Acne
Chang Gung Memorial Hospital
P1/2
CCC
(48)
Mitapivat
Hemolytic Anemia
National Heart, Lung, and Blood Institute (NHLBI)
P1/2
CCC
(48)
Mitoxantrone
Extranodal Nasal NK/T Cell Lymphoma
Beijing Tongren Hospital
P1/2
CCC
(48)
Mitoxantrone
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P1/2
CCC
(48)
mk-1084
Lung Cancer
Merck Sharp & Dohme LLC
P1/2
CCC
(48)
Modi-1 Moditope
Head And Neck Squamous Cell Carcinoma
Scancell Ltd
P1/2
CCC
(48)
Montanide Isa 51
Head And Neck Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Montanide Isa 51
Breast Cancer
ExpreS2ion Biotechnologies
P1/2
CCC
(48)
Montanide Isa 51
Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Montanide Isa 51
Skin Squamous Cell Carcinoma
Roswell Park Cancer Institute
P1/2
CCC
(48)
Showing 1476 to 1500 of 6,308 assets
Previous
Page 60 of 253
Next